Fig. 4.
Fig. 4. Upper figure compares the recovery of CD4+T cells after unrelated BMT in adults (right) and children (left) with that of adult recipients of a related SBA−E− BMT receiving the same cytoreductive regimen and graft rejection prophylaxis. Unrelated transplant recipients are shown as circles, and related transplant recipients are shown by the shaded gray area (10th-90th%; 50th% shown by white line). The figure also compares the CD4+ cell counts of patients who did (•) or did not (○) develop a life-threatening opportunistic infection during that time interval after unrelated BMT. The stippled rectangle denotes 10% to 90% normal control values. (Lower panel) CD4+ CD45RA recovery in adults (right) and children (left) after unrelated SBA−E− BMT (circles), compared with patients after SBA−E− related BMT (shaded gray area). The horizontal bar represents the median of patients studied within each time period. The stippled rectangle denotes 10th-90th% of normal controls.

Upper figure compares the recovery of CD4+T cells after unrelated BMT in adults (right) and children (left) with that of adult recipients of a related SBAE BMT receiving the same cytoreductive regimen and graft rejection prophylaxis. Unrelated transplant recipients are shown as circles, and related transplant recipients are shown by the shaded gray area (10th-90th%; 50th% shown by white line). The figure also compares the CD4+ cell counts of patients who did (•) or did not (○) develop a life-threatening opportunistic infection during that time interval after unrelated BMT. The stippled rectangle denotes 10% to 90% normal control values. (Lower panel) CD4+ CD45RA recovery in adults (right) and children (left) after unrelated SBAE BMT (circles), compared with patients after SBAE related BMT (shaded gray area). The horizontal bar represents the median of patients studied within each time period. The stippled rectangle denotes 10th-90th% of normal controls.

Close Modal

or Create an Account

Close Modal
Close Modal